ROLE OF DHT IN GNRH PULSE GENERATOR RESISTANCE TO STEROID FEEDBACK IN PCOS
DHT 在 GNRH 脉冲发生器对 PCOS 类固醇反馈抵抗中的作用
基本信息
- 批准号:7606677
- 负责人:
- 金额:$ 8.2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2008-02-29
- 项目状态:已结题
- 来源:
- 关键词:AccountingAndrogen ReceptorComputer Retrieval of Information on Scientific Projects DatabaseDefectDoseEnzyme Inhibitor DrugsEnzyme InhibitorsEstradiolEtiologyFeedbackFinasterideFlutamideFrequenciesFundingGonadotropin Hormone Releasing HormoneGrantHormonalInstitutionMediatingOxidoreductasePhysiologic pulsePolycystic Ovary SyndromeProgesteronePulse takingResearchResearch PersonnelResistanceResourcesRoleSourceStanoloneSteroidsTestosteroneUnited States National Institutes of HealthWeekWomanresponse
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Polycystic ovary syndrome (PCOS) is associated with a persistently rapid gonadotropin hormone-releasing hormone (GnRH) pulse frequency, an abnormality that may account for many of the hormonal manifestations of PCOS. Although the etiology of this rapid GnRH pulse frequency is unclear, recent evidence suggests that the GnRH pulse generator in PCOS is relatively resistant to the feedback effects of progesterone (P) and estradiol (E2). For example, one study evaluated LH (and by inference GnRH) pulse frequency before and 7 d after exogenous P and E2 administration. Assessment of LH suppression as a function of mean P concentration revealed that P concentrations <10 ng/ml suppressed LH pulse frequency more effectively in normal women than in those with PCOS. This abnormality is reversed by treatment with the androgen receptor antagonist flutamide, suggesting that the aforementioned sensitivity defect results from hyperandrogenemia. However, it is unknown whether testosterone (T) itself, or its more potent metabolite dihydrotestosterone (DHT), mediates these effects. We will examine this further with the use of finasteride, a specific inhibitor of the enzyme (5?-reductase) that catalyzes conversion of T to DHT. Subjects with PCOS and normal controls will be studied. Baseline LH pulse frequency will be determined. Finasteride will then be given for 4 weeks prior to reassessment of LH pulse frequency. Thereafter, exogenous P and E2 will be given in addition to finasteride for one week, after which LH pulse frequency will again be determined. In this way, we aim to construct a P dose-LH pulse frequency response curve (i.e., mean P concentration vs. change in LH pulse frequency) for women with PCOS and controls. We hypothesize that in PCOS, finasteride will restore GnRH pulse generator sensitivity to negative feedback by P and E2, suggesting that DHT mediates abnormal feedback sensitivity.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
多囊卵巢综合征(PCOS)与持续快速的促性腺激素激素释放激素(GNRH)脉冲频率有关,这种异常可能会解释PCOS的许多激素表现。尽管这种快速GNRH脉冲频率的病因尚不清楚,但最近的证据表明,PCOS中的GnRH脉冲发生器对孕酮(P)和雌二醇(E2)的反馈作用相对抵抗力。例如,一项研究在外源P和E2给药后评估了LH(和推理GNRH)脉冲频率和7 d。对LH抑制作的评估是平均P浓度的函数,表明PCOS的P浓度<10 ng/ml抑制LH脉冲频率比正常女性更有效。用雄激素受体拮抗剂氟丁酰胺治疗逆转了这种异常,这表明上述敏感性缺陷来自高雄激素血症。但是,尚不清楚睾丸激素(T)本身或其更有效的代谢产物二氢睾丸激素(DHT)是否介导了这些作用。我们将通过使用非那雄胺的使用,这是一种催化t转化为DHT的酶(5?还原酶)的特异性抑制剂。将研究具有PCOS和正常对照的受试者。将确定基线LH脉冲频率。然后,在重新评估LH脉冲频率之前,将给予非那雄胺4周。此后,除非那雄胺外,还将给出外源P和E2,此后将再次确定LH脉冲频率。通过这种方式,我们旨在为患有PCOS和对照的女性构建P剂量LH脉冲频率响应曲线(即平均P浓度与LH脉冲频率变化)。我们假设在PCOS中,非那雄胺将恢复P和E2对负反馈的GNRH脉冲发生器的敏感性,这表明DHT介导异常的反馈灵敏度。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christopher Rolland McCartney其他文献
Christopher Rolland McCartney的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christopher Rolland McCartney', 18)}}的其他基金
ROLE OF ANDROGENS IN THE NEUROENDOCRINE DYSFUNCTION OF NASCENT PCOS
雄激素在初生 PCOS 神经内分泌功能障碍中的作用
- 批准号:
10612821 - 财政年份:2019
- 资助金额:
$ 8.2万 - 项目类别:
ROLE OF ANDROGENS IN THE NEUROENDOCRINE DYSFUNCTION OF NASCENT PCOS
雄激素在初生 PCOS 神经内分泌功能障碍中的作用
- 批准号:
10025179 - 财政年份:2019
- 资助金额:
$ 8.2万 - 项目类别:
ROLE OF ANDROGENS IN THE NEUROENDOCRINE DYSFUNCTION OF NASCENT PCOS
雄激素在初生 PCOS 神经内分泌功能障碍中的作用
- 批准号:
10379444 - 财政年份:2019
- 资助金额:
$ 8.2万 - 项目类别:
PILOT PROJECT - FACTORS DETERMINING OBESITY-ASSOCIATED HYPERANDROGENEMIA IN GIRLS
试点项目 - 女孩肥胖相关高雄激素血症的决定因素
- 批准号:
8239999 - 财政年份:2011
- 资助金额:
$ 8.2万 - 项目类别:
Pubertal hyperandrogenemia, modification of day-night GnRH secretion, and PCOS
青春期高雄激素血症、昼夜 GnRH 分泌改变和 PCOS
- 批准号:
8089176 - 财政年份:2010
- 资助金额:
$ 8.2万 - 项目类别:
ETIOLOGICAL FACTORS OF OBESITY-ASSOC HYPERANDROGENEMIA IN PERIPUBERTAL GIRLS
青春期前后女孩肥胖相关高雄激素血症的病因
- 批准号:
8167184 - 财政年份:2010
- 资助金额:
$ 8.2万 - 项目类别:
SLEEP-WAKE LH FREQUENCY IN PERIPUBERTAL GIRLS WITH AND WITHOUT HYPERANDROGENEMIA
患有和不患有高雄激素血症的青春期前女孩的睡眠-觉醒 LH 频率
- 批准号:
8167195 - 财政年份:2010
- 资助金额:
$ 8.2万 - 项目类别:
DETERMINING RAPIDITY THAT EXOGENOUS P SUPPRESSES DAYTIME LH PULSE FREQUENCY
确定外源性 P 抑制日间 LH 脉搏频率的速度
- 批准号:
8167174 - 财政年份:2010
- 资助金额:
$ 8.2万 - 项目类别:
PROGESTERONE SUPPRESSION OF PUBERTAL NOCTURNAL LH
孕酮对青春期夜间 LH 的抑制
- 批准号:
8167146 - 财政年份:2010
- 资助金额:
$ 8.2万 - 项目类别:
相似国自然基金
靶向Sub-LBP的新型雄激素受体拮抗剂的发现及其抗前列腺癌活性研究
- 批准号:82304381
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
FMNL2介导的雄激素受体磷酸化促进前列腺癌恩扎卢胺耐药的作用及机制研究
- 批准号:82303885
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
雄激素-雄激素受体轴通过转录调控SAA1促进NETs介导肾癌免疫逃避的机制研究
- 批准号:82373225
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
HJURP调控PRDX1增加雄激素受体蛋白稳定性导致前列腺癌细胞对恩扎卢胺耐药的机制
- 批准号:82373188
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
雄激素受体AR介导雄激素调控林麝泌香的分子机制研究
- 批准号:32370560
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
CELLULAR AND MOLECULAR CHANGES ASSOCIATED WITH REPRODUCTIVE HEALTH
与生殖健康相关的细胞和分子变化
- 批准号:
8167857 - 财政年份:2010
- 资助金额:
$ 8.2万 - 项目类别:
ANDROGEN BLOCKADE AND SENSITIVITY OF THE GNRH PULSE GENERATOR
雄激素阻断和 GNRH 脉冲发生器的敏感性
- 批准号:
8167167 - 财政年份:2010
- 资助金额:
$ 8.2万 - 项目类别:
ID PROTEIN FAMILY EXPRESSION AND FUNCTION IN PROSTATE CANCER
ID 蛋白家族在前列腺癌中的表达和功能
- 批准号:
8166160 - 财政年份:2010
- 资助金额:
$ 8.2万 - 项目类别:
HYPERANDROGENEMIA & SLEEP-ASSOCIATED SLOWING OF FOLLICULAR LH FREQUENCY IN PCOS
高雄激素血症
- 批准号:
8167192 - 财政年份:2010
- 资助金额:
$ 8.2万 - 项目类别: